Pilot study explored the application of MDMA-assisted psychotherapy in 18 individuals experiencing moderate to severe anxiety following diagnosis with a life-threatening illness. The primary outcome, change …
McKenna Haynes and Robert Hallock, Ph.D Department of Psychology Purdue University This is roughly a 20 minute, completely anonymous survey that considers what the public has used psilocybin for during …
Today, the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) announced the publication of the long-term follow-up results of six Phase 2 clinical trials of MDMA-assisted psychotherapy …
On May 12, 2020, a new protocol amendment which increases the number of study participants to a total of 120 was accepted by the U.S. Food and Drug Administration (FDA). This protocol amendment was submitted …
As of January 17, 2020, 89 total participants are enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
As of December 18, 2019, 87 total participants are enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
As of November 15, 2019, 83 total participants are enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
On Tuesday, October 15, researchers from MAPS Public Benefit Corporation (MAPS PBC) conducted the official site initiation visit for our new study site location in Santa Fe, New Mexico, for our ongoing …
We are launching a third study location in Santa Fe, New Mexico, for our ongoing therapist training study, which also takes place in Boulder, Colorado, and Charleston, South Carolina. The new study site …
As of August 28, 2019, 81 total participants are enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
On June 5, 2019, the 79th participant enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this multi-site …
